ACG Wealth Acquires 295 Shares of UnitedHealth Group Incorporated (NYSE:UNH)

ACG Wealth boosted its holdings in shares of UnitedHealth Group Incorporated (NYSE:UNHGet Rating) by 23.2% during the 2nd quarter, according to its most recent filing with the Securities and Exchange Commission. The firm owned 1,569 shares of the healthcare conglomerate’s stock after purchasing an additional 295 shares during the quarter. ACG Wealth’s holdings in UnitedHealth Group were worth $806,000 at the end of the most recent quarter.

Other large investors have also added to or reduced their stakes in the company. Advocacy Wealth Management Services LLC increased its stake in UnitedHealth Group by 75.8% in the 1st quarter. Advocacy Wealth Management Services LLC now owns 58 shares of the healthcare conglomerate’s stock worth $30,000 after acquiring an additional 25 shares during the last quarter. Cascade Investment Advisors Inc. increased its position in shares of UnitedHealth Group by 100.0% during the 1st quarter. Cascade Investment Advisors Inc. now owns 60 shares of the healthcare conglomerate’s stock valued at $31,000 after purchasing an additional 30 shares during the last quarter. Rise Advisors LLC bought a new position in shares of UnitedHealth Group during the 4th quarter valued at approximately $38,000. Evolution Advisers Inc. bought a new position in shares of UnitedHealth Group during the 1st quarter valued at approximately $38,000. Finally, Cordant Inc. purchased a new position in UnitedHealth Group during the 1st quarter valued at $45,000. Institutional investors own 87.25% of the company’s stock.

Insider Buying and Selling at UnitedHealth Group

In other UnitedHealth Group news, CAO Thomas E. Roos sold 465 shares of the firm’s stock in a transaction that occurred on Friday, August 26th. The stock was sold at an average price of $542.37, for a total value of $252,202.05. Following the sale, the chief accounting officer now directly owns 34,786 shares of the company’s stock, valued at $18,866,882.82. The sale was disclosed in a filing with the SEC, which can be accessed through the SEC website. In other news, CAO Thomas E. Roos sold 465 shares of UnitedHealth Group stock in a transaction that occurred on Friday, August 26th. The stock was sold at an average price of $542.37, for a total value of $252,202.05. Following the sale, the chief accounting officer now directly owns 34,786 shares of the company’s stock, valued at $18,866,882.82. The sale was disclosed in a filing with the Securities & Exchange Commission, which is accessible through this hyperlink. Also, CEO Andrew Witty sold 11,376 shares of UnitedHealth Group stock in a transaction that occurred on Monday, July 18th. The stock was sold at an average price of $527.90, for a total value of $6,005,390.40. Following the completion of the sale, the chief executive officer now directly owns 76,559 shares in the company, valued at $40,415,496.10. The disclosure for this sale can be found here. Over the last three months, insiders have sold 139,051 shares of company stock valued at $74,450,958. Company insiders own 0.40% of the company’s stock.

Analyst Upgrades and Downgrades

Several equities analysts have commented on the company. Mizuho upped their price objective on UnitedHealth Group from $550.00 to $600.00 and gave the company a “buy” rating in a research report on Wednesday, August 10th. Deutsche Bank Aktiengesellschaft increased their price target on UnitedHealth Group from $556.00 to $569.00 and gave the stock a “buy” rating in a research report on Thursday, September 8th. Oppenheimer increased their price target on UnitedHealth Group from $600.00 to $610.00 and gave the stock an “outperform” rating in a research report on Monday, July 18th. SVB Leerink raised their price objective on UnitedHealth Group from $600.00 to $625.00 and gave the company an “outperform” rating in a research report on Monday, July 18th. Finally, Raymond James raised their price objective on UnitedHealth Group from $620.00 to $635.00 in a research report on Thursday. Three research analysts have rated the stock with a hold rating, fifteen have issued a buy rating and two have assigned a strong buy rating to the company. Based on data from MarketBeat.com, the company currently has an average rating of “Moderate Buy” and a consensus target price of $586.40.

UnitedHealth Group Trading Up 1.1 %

Shares of NYSE:UNH opened at $517.46 on Friday. UnitedHealth Group Incorporated has a 52-week low of $383.12 and a 52-week high of $553.29. The stock has a market cap of $484.02 billion, a price-to-earnings ratio of 27.02, a PEG ratio of 1.61 and a beta of 0.76. The company has a quick ratio of 0.77, a current ratio of 0.77 and a debt-to-equity ratio of 0.60. The business has a 50-day moving average price of $530.11 and a 200-day moving average price of $512.45.

UnitedHealth Group (NYSE:UNHGet Rating) last posted its earnings results on Friday, July 15th. The healthcare conglomerate reported $5.57 EPS for the quarter, topping the consensus estimate of $5.24 by $0.33. The firm had revenue of $80.33 billion for the quarter, compared to analyst estimates of $79.68 billion. UnitedHealth Group had a return on equity of 25.45% and a net margin of 5.95%. UnitedHealth Group’s revenue for the quarter was up 12.6% compared to the same quarter last year. During the same period last year, the company earned $4.70 earnings per share. Equities analysts predict that UnitedHealth Group Incorporated will post 21.85 EPS for the current year.

UnitedHealth Group Dividend Announcement

The firm also recently disclosed a quarterly dividend, which was paid on Tuesday, September 20th. Shareholders of record on Monday, September 12th were issued a $1.65 dividend. This represents a $6.60 annualized dividend and a yield of 1.28%. The ex-dividend date was Friday, September 9th. UnitedHealth Group’s payout ratio is currently 34.46%.

UnitedHealth Group Company Profile

(Get Rating)

UnitedHealth Group Incorporated operates as a diversified health care company in the United States. It operates through four segments: UnitedHealthcare, Optum Health, Optum Insight, and Optum Rx. The UnitedHealthcare segment offers consumer-oriented health benefit plans and services for national employers, public sector employers, mid-sized employers, small businesses, and individuals; health care coverage and well-being services to individuals age 50 and older addressing their needs for preventive and acute health care services, as well as services dealing with chronic disease and other specialized issues for older individuals; Medicaid plans, children's health insurance and health care programs; health and dental benefits; and hospital and clinical services.

Read More

Want to see what other hedge funds are holding UNH? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for UnitedHealth Group Incorporated (NYSE:UNHGet Rating).

Institutional Ownership by Quarter for UnitedHealth Group (NYSE:UNH)

Receive News & Ratings for UnitedHealth Group Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for UnitedHealth Group and related companies with MarketBeat.com's FREE daily email newsletter.